Charlotte’s Web: Surviving A Noisy, Crowded, Confusing CBD Market (SeekingAlpha).
12/1/19 CWEB $11.83, CWBHF $8.89
Summary
CWEB reported 2019 Q3 results which showed revenue stagnating and EBITDA margin dropping to barely above break-even.The collapse in...
What You Need to Know About CBD, the FDA.
What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD (November 2019)
The FDA...
Adding Slang Worldwide (SLNG.CN SLGWF) to Watch List.
Enough is enough here. Adding to Marijuana Stock Review 2020 Bounce Portfolio Watch List - After Being Trounced from $2.80 CDN to $0.44 CDN.
https://vimeo.com/360353219
Company...
Updating Coverage on Nass Valley Gateway (NVG.CN NSVGF).
Prepping for 1st Quarter 2020 CBD Launch.
Revolutionizing
the Way CBD is Marketed
Stage
I of the CBD explosion is in
full gear, already generating billions in sales collectively...
Tinley Beverage (TNY.CN, TNYBF) Presentation – December 5th, 10AM EST.
VirtualInvestorConferences.com
NEW YORK, Nov. 25, 2019 /PRNewswire/ -- Virtual Investor Conferences today announced the agenda for the upcoming Virtual lnvestor Conference, the leading proprietary investor conference series....
Charlotte’s Web (CWEB, CWBHF). Buy the Dip – Don’t Buy the...
Battle Rages on SeekingAlpha.
Excerpts from both cases:
BUY THE DIP:
Summary
Charlotte's Web's Q3 earnings results demonstrate positive (albeit slowing) YoY revenue growth.
The company is clearly...
Technical Signals Turning Up at Nass Valley Gateway (NVG.CN, NSVGF) $0.21...
Shares of Nass Valley Gateway Have
Turned up Recently on the Heels of News of an Expected Launch Date in Early Q1
2020.
We added Nass Valley...
Former FDA Head Scott Gottlieb on Vaping.
Remarks from the 19th Annual Marshall J. Seidman Lecture Series.
A travesty on top of a travesty.
November 13, 2019
This is a burgeoning epidemic....
Former FDA Head Scott Gottlieb Tells a Worrisome Tale About CBD...
CBD Is Not Safe, Says Former FDA Chief Scott Gottlieb (MotleyFool).
You see, while hemp-based CBD may have been given a pretty clear sales pathway...
